SEC Form 4 · accession 0001144204-15-053227
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Manzo
Officer — Vice President of Engineering
Period of report
Aug 28, 2015
Accepted (ET)
Sep 1, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 28, 2015 | A | 5,926 | $0.00 | A | 12,261 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $3.59 | Aug 28, 2015 | A | 10,000 | A | — | Aug 28, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The Reporting Person received Restricted Shares from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Restricted Shares are not subject to vesting.
- F2The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option became exercisable as to 25% of the shares underlying the Option on August 28, 2015, 25% of the shares underlying the Option become exercisable on August 28, 2016, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Remarks
*Signed under power of attorney on behalf of Reporting Person